Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  2018-12-22

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/5584_2018_318PMID 30578461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.

  2019cited by this paper
• Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.

  2018cited by this paper
• Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis

  2018cited by this paper
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns

  2018cited by this paper
• Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease.

  2018cited by this paper
• Liver-Microbiome Axis in Health and Disease.

  2018cited by this paper
• Nonalcoholic Fatty Liver Disease in Children

  2018cited by this paper
• Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.

  2017cited by this paper
• Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease

  2017cited by this paper
• Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

  2017cited by this paper
• Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.

  2017cited by this paper
• Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study

  2017cited by this paper
• Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota

  2017cited by this paper
• The intestinal microbiome and paediatric liver disease.

  2017cited by this paper
• Environmental Factors Affecting Growth and Occurrence of Testicular Cancer in Childhood: An Overview of the Current Epidemiological Evidence

  2017cited by this paper
• Fecal microbiota transplantation in metabolic syndrome: History, present and future

  2017cited by this paper
• Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents

  2017cited by this paper
• Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile

  2017cited by this paper
• Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.

  2016cited by this paper
• Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature

  2016cited by this paper
• Foodomics as part of the host-microbiota-exposome interplay.

  2016cited by this paper
• Antibiotic administration and the development of obesity in children.

  2016cited by this paper
• Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

  2016cited by this paper
• The role of Clostridium difficile in the paediatric and neonatal gut — a narrative review

  2016cited by this paper
• Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions

  2016cited by this paper
• Breastfeeding Practices among Native Hawaiians and Pacific Islanders

  2016cited by this paper
• Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?

  2016cited by this paper
• Gut Microbiota of Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease

  2015cited by this paper
• Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease

  2015cited by this paper
• Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Additional file 11: Table S8. of Structure and function of the healthy pre-adolescent pediatric gut microbiome

  2015cited by this paper
• Fecal Microbiota in Healthy Subjects Following Omnivore, Vegetarian and Vegan Diets: Culturable Populations and rRNA DGGE Profiling

  2015cited by this paper
• Gut microbiome and nonalcoholic fatty liver diseases

  2015cited by this paper
• Molecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune System

  2015cited by this paper
• Bacteriophage application restores ethanol fermentation characteristics disrupted by Lactobacillusfermentum

  2015cited by this paper
• Structure and function of the healthy pre-adolescent pediatric gut microbiome

  2015cited by this paper
• Probiotics in digestive diseases: focus on Lactobacillus GG.

  2015cited by this paper
• 850f Anti-NASH Effects of Solithromycin in NASH-HCC Mouse Model

  2014cited by this paper
• Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome

  2014cited by this paper
• Diet and the intestinal microbiome: associations, functions, and implications for health and disease.

  2014cited by this paper
• Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications

  2014cited by this paper
• Metabolic Modeling of Common Escherichia coli Strains in Human Gut Microbiome

  2014cited by this paper
• Dietary Blueberry and Bifidobacteria Attenuate Nonalcoholic Fatty Liver Disease in Rats by Affecting SIRT1-Mediated Signaling Pathway

  2014cited by this paper
• Geographical variation of human gut microbial composition

  2014cited by this paper
• Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

  2014cited by this paper
• Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.

  2014cited by this paper
• Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis

  2014cited by this paper
• Evaluation and Integration of Genetic Signature for Prediction Risk of Nasopharyngeal Carcinoma in Southern China

  2014cited by this paper
• Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

  2014cited by this paper
• Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.

  2014cited by this paper
• Intestinal microbiota in patients with nonalcoholic fatty liver disease

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Intronic Cis-Regulatory Modules Mediate Tissue-Specific and Microbial Control of angptl4/fiaf Transcription

  2012cited by this paper
• Gastrointestinal Microbiota and Some Children Diseases: A Review

  2012cited by this paper
• Distinct Gut Microbiota in Southeastern African and Northern European Infants

  2012cited by this paper
• Irritable Bowel Syndrome and Psychiatric Disorders in Pakistan: A Case Control Study

  2012cited by this paper
• Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

  2012cited by this paper
• Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

  2011cited by this paper
• Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats

  2011cited by this paper
• Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.

  2011cited by this paper
• Effects of four Bifidobacteria on obesity in high-fat diet induced rats.

  2010cited by this paper
• La microbiota intestinal: Un nuevo actor en el desarrollo de la obesidad

  2010cited by this paper
• Microbiota and SCFA in Lean and Overweight Healthy Subjects

  2010cited by this paper
• The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• [The association of intestinal microbiota with obesity].

  2010cited by this paper
• The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

  2009cited by this paper
• Nonalcoholic Fatty Liver Disease in Children

  2008cited by this paper
• Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.

  2003cited by this paper
• Validation of the Probiotic Concept: Lactobacillus reuteri Confers Broad-spectrum Protection against Disease in Humans and Animals

  2000cited by this paper
• Review: The treatment and prevention of obesity: a systematic review of the literature

  1997cited by this paper
• The treatment and prevention of obesity: a systematic review of the literature.

  1997cited by this paper

• Bidirectional interplay between the gut microbiota and GLP-1 receptor agonists: towards Microbiome-Mediated therapeutics in type 2 diabetes mellitus

  2026cites this paper
• Clinical efficacy evaluation of washed microbiota transplantation treatment for metabolic related fatty liver disease and its impact on tongue coating microorganisms

  2025cites this paper
• A systematic Mendelian randomized study of the effects of the gut microbiome and immune cells on pancreatic neuroendocrine tumors

  2025cites this paper
• Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway

  2025cites this paper
• Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention

  2022cites this paper
• Polyphenol-Rich Liupao Tea Extract Prevents High-Fat Diet-Induced MAFLD by Modulating the Gut Microbiota

  2022cites this paper
• Biome Profiling and Clinical Parasitology: Tools for Gut Microbiota Restoring

  2021cites this paper
• Deposition of resistant bacteria and resistome through FMT in germ‐free piglets

  2021cites this paper
• Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism

  2021cites this paper
• The gut microbiota and gut disease

  2021cites this paper
• Effects of probiotics on inflammatory bowel disease: A systematic review

  2021cites this paper
• An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Intestinal Microecology: An Important Target for Chinese Medicine Treatment of Non-alcoholic Fatty Liver Disease

  2020cites this paper
• Recent advances in modulating the microbiome

  2020cites this paper
• The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis

  2019cites this paper
• Potential of multiomics technology in precision medicine

  2019cites this paper